(Q73889210)

English

Interactions between outcomes and tumor response to preoperative cisplatin-sensitized radiotherapy in advanced head and neck cancer. Southern New Jersey Head and Neck Cancer Treatment Group

scientific article published on 01 November 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Interactions between outcomes and tumor response to preoperative cisplatin-sensitized radiotherapy in advanced head and neck cancer. Southern New Jersey Head and Neck Cancer Treatment Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

head and neck cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

head and neck carcinoma

1 reference

based on heuristic

inferred from title

author name string

M D Goodman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Tarnoff

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Kain

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

G J Slotman

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

0 references

publication date

1 November 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

The American Journal of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

174

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

527-531

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Another look at induction chemotherapy for organ preservation in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Continuous course radiation therapy and concurrent combination chemotherapy for squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Double-blind randomized study of lonidamine and radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Preoperative simultaneously administered cis-platinum plus radiation therapy for advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Preoperative combined chemotherapy and radiation therapy plus radical surgery in advanced head and neck cancer. Five-year results with impressive complete response rates and high survival

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Cisplatin as a radiation sensitizer in the treatment of advanced head and neck cancers. Results of a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Concurrent radiation therapy, 5-fluorouracil, and cisplatin for stage II, III, and IV, node-negative, squamous cell head and neck cancer. Results and surgical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil, both in continuous 96-hour infusion, in the treatment of locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

THE LEVEL OF CERVICAL LYMPH NODE METASTASES: THEIR PROGNOSTIC RELEVANCE AND RELATIONSHIP WITH HEAD AND NECK SQUAMOUS CARCINOMA PRIMARY SITES

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Lymph node prognostic factors in head and neck squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Predicting factors for distant metastases in head and neck carcinomas: an analysis of 103 patients with locoregional control

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Plasma platelet-derived growth factor: preliminary study of a potential marker in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Growth factor mRNA expression in human head and neck malignant tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Significance of thrombocytosis in patients with epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Prognostic significance of thrombocytosis in patients with primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Plasma thromboxane A2 and prostacyclin concentrations in squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Tumor-associated tissue eosinophilia and long-term prognosis for carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Sedimentation rate and serum thymidine kinase activity: prognostic factors in squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

The clinical application of DNA content and kinetic parameters in the treatment of patients with squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2897%2900151-7

7 January 2021

Identifiers

10.1016/S0002-9610(97)00151-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9374230%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73889210&oldid=1747164096"